Published in Breast Cancer Res Treat on July 01, 2001
The influence of race, ethnicity, and individual socioeconomic factors on breast cancer stage at diagnosis. Am J Public Health (2006) 2.20
Risk factors for triple-negative breast cancer in women under the age of 45 years. Cancer Epidemiol Biomarkers Prev (2009) 2.00
Parity and lactation in relation to estrogen receptor negative breast cancer in African American women. Cancer Epidemiol Biomarkers Prev (2011) 1.71
Identification of novel kinase targets for the treatment of estrogen receptor-negative breast cancer. Clin Cancer Res (2009) 1.48
Triple receptor-negative breast cancer: the effect of race on response to primary systemic treatment and survival outcomes. J Clin Oncol (2008) 1.46
Estrogen receptor positive tumors: do reproductive factors explain differences in incidence between black and white women? Cancer Causes Control (2013) 1.46
Breast cancer screening, area deprivation, and later-stage breast cancer in Appalachia: does geography matter? Health Serv Res (2013) 1.32
Race/ethnicity and breast cancer estrogen receptor status: impact of class, missing data, and modeling assumptions. Cancer Causes Control (2008) 1.19
A collaborative study of the etiology of breast cancer subtypes in African American women: the AMBER consortium. Cancer Causes Control (2013) 1.17
Disparities in breast cancer outcomes between Caucasian and African American women: a model for describing the relationship of biological and nonbiological factors. Breast Cancer Res (2013) 1.08
Oral contraceptive use and estrogen/progesterone receptor-negative breast cancer among African American women. Cancer Epidemiol Biomarkers Prev (2010) 1.08
Racial disparities in the development of breast cancer metastases among older women: a multilevel study. Cancer (2009) 1.00
Breast cancer burden in central Sudan. Int J Womens Health (2010) 0.96
Racial differences in outcomes of triple-negative breast cancer. Breast Cancer Res Treat (2013) 0.93
Pathologic complete response in breast cancer patients receiving anthracycline- and taxane-based neoadjuvant chemotherapy: evaluating the effect of race/ethnicity. Cancer (2010) 0.90
Associations of hormone-related factors with breast cancer risk according to hormone receptor status among white and African American women. Clin Breast Cancer (2014) 0.89
Replication of breast cancer susceptibility loci in whites and African Americans using a Bayesian approach. Am J Epidemiol (2013) 0.84
A prospective study of physical activity and breast cancer incidence in African-American women. Cancer Epidemiol Biomarkers Prev (2014) 0.84
A population-based study of Kurdish breast cancer in northern Iraq: hormone receptor and HER2 status. A comparison with Arabic women and United States SEER data. BMC Womens Health (2012) 0.83
The association between the pre-diagnosis mammography screening interval and advanced breast cancer. Breast Cancer Res Treat (2006) 0.83
Breast cancer biologic and etiologic heterogeneity by young age and menopausal status in the Carolina Breast Cancer Study: a case-control study. Breast Cancer Res (2016) 0.77
Enhanced down-regulation of ALCAM/CD166 in African-American Breast Cancer. BMC Cancer (2014) 0.76
Breast cancers from black women exhibit higher numbers of immunosuppressive macrophages with proliferative activity and of crown-like structures associated with lower survival compared to non-black Latinas and Caucasians. Breast Cancer Res Treat (2016) 0.76
Failure patterns and survival outcomes in triple negative breast cancer (TNBC): a 15 year comparison of 448 non-Hispanic black and white women. Springerplus (2016) 0.75
Rational Manual and Automated Scoring Thresholds for the Immunohistochemical Detection of TP53 Missense Mutations in Human Breast Carcinomas. Appl Immunohistochem Mol Morphol (2016) 0.75
Predicted 25-hydroxyvitamin D in relation to incidence of breast cancer in a large cohort of African American women. Breast Cancer Res (2016) 0.75
Linkage of early-onset familial breast cancer to chromosome 17q21. Science (1990) 16.21
Use and misuse of population attributable fractions. Am J Public Health (1998) 12.96
Vascular cell adhesion molecule-1 mediates lymphocyte adherence to cytokine-activated cultured human endothelial cells. Blood (1990) 3.65
Abrogation of the Rb/p16 tumor-suppressive pathway in virtually all pancreatic carcinomas. Cancer Res (1997) 3.17
Hormone-related factors and risk of breast cancer in relation to estrogen receptor and progesterone receptor status. Am J Epidemiol (2000) 2.93
Aberrant promoter methylation of multiple genes in non-small cell lung cancers. Cancer Res (2001) 2.80
Maximum likelihood estimation of haplotype effects and haplotype-environment interactions in association studies. Genet Epidemiol (2005) 2.77
Poisoning with maprotiline and mianserin. Br Med J (1977) 2.64
Ductal epithelial proliferations of the breast: a biological continuum? Comparative genomic hybridization and high-molecular-weight cytokeratin expression patterns. J Pathol (2001) 2.33
The Carolina Breast Cancer Study: integrating population-based epidemiology and molecular biology. Breast Cancer Res Treat (1995) 2.31
Population attributable fraction estimation for established breast cancer risk factors: considering the issues of high prevalence and unmodifiability. Am J Epidemiol (1998) 2.27
Inactivation of the p16 (INK4A) tumor-suppressor gene in pancreatic duct lesions: loss of intranuclear expression. Cancer Res (1998) 2.23
Participation rates in a case-control study: the impact of age, race, and race of interviewer. Ann Epidemiol (1999) 2.21
Paracetamol poisoning in children. Br Med J (1978) 2.17
Excess maternal transmission of type 2 diabetes. The Northern California Kaiser Permanente Diabetes Registry. Diabetes Care (1999) 2.11
Effects of passive immunization on experimental syphilis in the rabbit. Johns Hopkins Med J (1973) 2.07
A high proportion of novel mutations in BRCA1 with strong founder effects among Dutch and Belgian hereditary breast and ovarian cancer families. Am J Hum Genet (1997) 2.01
Protective role of appendicectomy on onset and severity of ulcerative colitis and Crohn's disease. Gut (2002) 1.96
Demonstration of a virus-like agent contaminating material containing the Stockholm substrain of the Nichols pathogenic Treponema pallidum. Br J Vener Dis (1970) 1.74
Environmental contaminants and body fat distribution. Cancer Epidemiol Biomarkers Prev (1999) 1.74
Infectivity tests in syphilis. Br J Vener Dis (1969) 1.73
ELFT: a gene that directs the expression of an ELAM-1 ligand. Cell (1990) 1.70
Area-level characteristics and smoking in women. Am J Public Health (2001) 1.68
Are heavy smokers different from light smokers? A comparison after 48 hours without cigarettes. JAMA (1988) 1.65
Familial and personal medical history of cancer and nervous system conditions among adults with glioma and controls. Am J Epidemiol (1997) 1.63
Catechol-O-methyltransferase and breast cancer risk. Carcinogenesis (1998) 1.58
Body size and breast cancer risk in black women and white women: the Carolina Breast Cancer Study. Am J Epidemiol (2000) 1.58
High-grade non-Hodgkin lymphoma relapsing as low-grade follicular lymphoma: so-called downgraded lymphoma. Am J Hematol (1989) 1.57
Genetic polymorphisms in uridine diphospho-glucuronosyltransferase 1A1 and association with breast cancer among African Americans. Cancer Res (2000) 1.55
Genetic and behavioral determinants of waist-hip ratio and waist circumference in women twins. Obes Res (1998) 1.53
Heterocyclic amines, meat intake, and association with colon cancer in a population-based study. Am J Epidemiol (2003) 1.51
Prevalence and clinical features of HTLV neurologic disease in the HTLV Outcomes Study. Neurology (2003) 1.51
A blocking monoclonal antibody to endothelial-leukocyte adhesion molecule-1 (ELAM1). Biochem Biophys Res Commun (1990) 1.50
5' CpG island methylation of the FHIT gene is correlated with loss of gene expression in lung and breast cancer. Cancer Res (2001) 1.46
Genetic and behavioral influences on body fat distribution. Int J Obes (1990) 1.43
The effect of short-term, temporary deferral on future blood donation. Transfusion (1998) 1.43
Cigarette smoking, N-acetyltransferases 1 and 2, and breast cancer risk. Cancer Epidemiol Biomarkers Prev (1998) 1.43
Inheritance of low-density lipoprotein subclass patterns: results of complex segregation analysis. Am J Hum Genet (1988) 1.42
Aggressive jejunal lymphoma of large granular lymphocytes. Immunohistochemical, ultrastructural, molecular, and DNA content analysis. Am J Clin Pathol (1990) 1.42
Hematogones: a multiparameter analysis of bone marrow precursor cells. Blood (1989) 1.42
Rb and p16INK4a expression in resected non-small cell lung tumors. Cancer Res (1996) 1.41
Infectivity tests in syphilis. 1969. Sex Transm Infect (2000) 1.39
Human breast cancer specimens: diffraction-enhanced imaging with histologic correlation--improved conspicuity of lesion detail compared with digital radiography. Radiology (2000) 1.39
Expression and functional characterization of a soluble form of vascular cell adhesion molecule 1. Biochem Biophys Res Commun (1991) 1.37
Genetic and environmental influences on insulin levels and the insulin resistance syndrome: an analysis of women twins. Am J Epidemiol (1996) 1.35
Polymorphisms in the DNA repair gene XRCC1 and breast cancer. Cancer Epidemiol Biomarkers Prev (2001) 1.35
Evaluation of a treatment approach combining nicotine gum with self-guided behavioral treatments for smoking relapse prevention. J Consult Clin Psychol (1990) 1.31
Loss of p16(INK4a) expression correlates with decreased survival in pediatric osteosarcomas. Int J Cancer (2001) 1.30
Multivariate analysis of the insulin resistance syndrome in women. Arterioscler Thromb (1994) 1.29
Increased prevalence of infectious diseases and other adverse outcomes in human T lymphotropic virus types I- and II-infected blood donors. Retrovirus Epidemiology Donor Study (REDS) Study Group. J Infect Dis (1997) 1.28
Heritability of longitudinal changes in coronary-heart-disease risk factors in women twins. Am J Hum Genet (1997) 1.28
Simian virus 40 small tumor antigen and an amino-terminal domain of large tumor antigen share a common transforming function. Proc Natl Acad Sci U S A (1990) 1.27
Splenic lymphangiomatosis in children. Radiology (1997) 1.24
Correlations among human blood levels of specific PCB congeners and implications for epidemiologic studies. Am J Ind Med (1997) 1.22
Venereal spirochetosis of rabbits (rabbit syphilis) due to Treponema cuniculi: a clinical, serological, and histopathological study. Lab Anim Sci (1972) 1.22
Rapid reporting of cancer incidence in a population-based study of breast cancer: one constructive use of a central cancer registry. Breast Cancer Res Treat (1995) 1.21
Alcohol consumption and breast cancer among black and white women in North Carolina (United States). Cancer Causes Control (2000) 1.20
The prognostic value of angiogenesis factor expression for predicting recurrence and metastasis of bladder cancer after neoadjuvant chemotherapy and radical cystectomy. Clin Cancer Res (2000) 1.20
Prognostic factors in early breast carcinoma. Cancer (1994) 1.20
Who will relapse? Symptoms of nicotine dependence predict long-term relapse after smoking cessation. J Consult Clin Psychol (1992) 1.19
Association between high-density lipoprotein cholesterol and breast cancer varies by menopausal status. Cancer Epidemiol Biomarkers Prev (1998) 1.19
The need for epidemiologic studies of in-situ carcinoma of the breast. Breast Cancer Res Treat (1995) 1.18
HER-2/neu and p53 expression versus tamoxifen resistance in estrogen receptor-positive, node-positive breast cancer. J Clin Oncol (2000) 1.17
Upregulation of VEGF-A and CD24 gene expression by the tGLI1 transcription factor contributes to the aggressive behavior of breast cancer cells. Oncogene (2011) 1.17
Race, anthropometric factors, and stage at diagnosis of breast cancer. Am J Epidemiol (2001) 1.16
Lymphedema secondary to breast cancer: how choice of measure influences diagnosis, prevalence, and identifiable risk factors. Lymphology (2008) 1.14
Loss of KAI1 expression in the progression of colorectal cancer. Cancer Res (1999) 1.13
Loss of p16/CDKN2A tumor suppressor protein in gastric adenocarcinoma is associated with Epstein-Barr virus and anatomic location in the body of the stomach. Hum Pathol (2000) 1.13
Interactive effects of depression symptoms, nicotine dependence, and weight change on late smoking relapse. J Consult Clin Psychol (1996) 1.12
Left mainstem bronchial narrowing: a vascular compression syndrome? Evaluation by magnetic resonance imaging. Pediatr Radiol (1998) 1.12
Partial inactivation of the RB product in a family with incomplete penetrance of familial retinoblastoma and benign retinal tumors. Oncogene (1994) 1.12
Alcohol consumption and insulin concentrations. Role of insulin in associations of alcohol intake with high-density lipoprotein cholesterol and triglycerides. Circulation (1993) 1.11
Development and implementation of a science training course for breast cancer activists: Project LEAD (leadership, education and advocacy development). Health Expect (2001) 1.10
Age at menarche, time to regular cycling, and breast cancer (North Carolina, United States). Cancer Causes Control (1998) 1.09
Lactation and breast cancer risk. Int J Epidemiol (1999) 1.08
Dichlorodiphenyldichloroethene, polychlorinated biphenyls, and breast cancer among African-American and white women in North Carolina. Cancer Epidemiol Biomarkers Prev (2000) 1.07
Abnormal Fhit expression in malignant and premalignant lesions of the cervix. Cancer Res (1999) 1.07
Molecular analysis of SALL1 mutations in Townes-Brocks syndrome. Am J Hum Genet (1999) 1.07
Attitudes toward genetic testing in patients with colorectal cancer. Cancer Pract (2002) 1.06
Why be moral: Humanist and behavioral perspectives. Behav Anal (1996) 1.06
The effects of phenotypic plasticity on genetic correlations. Trends Ecol Evol (1991) 1.05
Glutathione S-transferases M1, T1, and P1 and breast cancer. Cancer Epidemiol Biomarkers Prev (2000) 1.05
Environmental and behavioral determinants of fasting plasma glucose in women. A matched co-twin analysis. Am J Epidemiol (1987) 1.05
Immunohistochemical analysis of the p16INK4 cyclin-dependent kinase inhibitor in malignant mesothelioma. J Natl Cancer Inst (1995) 1.04
Usual dietary fat intake and insulin concentrations in healthy women twins. Diabetes Care (1993) 1.04
Single nucleotide polymorphisms (SNPs) in the estrogen receptor gene and breast cancer susceptibility. J Steroid Biochem Mol Biol (1999) 1.03
Risk of breast cancer according to the status of HER-2/neu oncogene amplification. Cancer Epidemiol Biomarkers Prev (2000) 1.03
Re-expression of p16INK4a in mesothelioma cells results in cell cycle arrest, cell death, tumor suppression and tumor regression. Oncogene (1998) 1.02
Internal hernia and volvulus of the small bowel following liver transplantation. Transpl Int (1997) 1.02
Lack of suppressor cell activity in systemic lupus erythematosus. Clin Immunol Immunopathol (1979) 1.02
The associations of adolescent cigarette smoking, alcoholic beverage consumption, environmental tobacco smoke, and ionizing radiation with subsequent breast cancer risk (United States). Cancer Causes Control (2000) 1.00
Bowel perforation in Hirschsprung's disease. AJR Am J Roentgenol (1987) 0.99
Epstein-Barr virus in gastric adenocarcinomas: association with ethnicity and CDKN2A promoter methylation. J Clin Pathol (2002) 0.99
Menstrual risk factors and early-onset breast cancer. Cancer Causes Control (2000) 0.99
Inherited predisposition to breast and ovarian cancer. Am J Hum Genet (1994) 0.98